The trademark CORVANDIN was filed by GLAXO GROUP LIMITED, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on July 24, 2005, and received one opposition filed on October 12, 2005 by Novartis AG on Likelihood of confusion. the opponent was represented by SPLANEMANN PATENTANWÄLTE PARTNERSCHAFT MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 12, 2005
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Deletion of the representative of the trademark registration was recorded on November 13, 2006.